Abstract Cannabidiol (CBD), a non-psychoactive cannabinoid, has been studied for its various health-promoting effects recently. This study investigates the effects…
Abstract Recreational cannabis access laws are associated with later sleep onset. Sleep duration was 5.37 minutes shorter after recreational legalization.…
Abstract Objective: Human sleep is fundamental for the proper occurrence of organic functions. Hence, lack of sleep can impair cognitive…
Abstract Background: Adolescent-onset cannabis use confers higher risk for neuropsychiatric disorders, implicating amygdala dysfunction. However, the mechanisms that mediate Δ9-tetrahydrocannabinol…
Keywords: cannabis, THC, CBD, Parkinson’s disease, cognition, insomnia, sleepiness, case series Authors: Ana Carolina Ruver-Martins, Ingrid Andrea Rodriguez Martinez, Vinicius…
Abstract Background and Aims: Conduct a pilot randomized double‐blind placebo‐controlled crossover trial for adults with subthreshold insomnia symptoms to examine…
Abstract Background and objective: Non-motor symptoms frequently develop throughout the disease course of Parkinson’s disease (PD), and pose affected individuals…
Abstract Introduction: Approximately 4% of the UK population experiences PTSD. Individuals must exhibit symptoms across four clusters to receive a…
Abstract Substance use disorder is a major global health concern, with a high prevalence among adolescents and young adults. The…
Abstract Background: Cannabidiol (CBD) is a non-psychoactive phyto-cannabinoid derived from the Cannabis sativa plant. CBD exhibits various interactions at receptor…